MedPath

Study the effect of drug on awakening time of patient and its quality after completion of surgery

Not Applicable
Completed
Conditions
Health Condition 1: null- cholithiasis for laparoscopic cholesystectomy
Registration Number
CTRI/2018/05/013679
Lead Sponsor
SGRDIMSAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

ASA physical status I and II

Either sex

Scheduled for laparoscopic cholecystectomy under GA

Exclusion Criteria

ASA III and above

Major hepatic, renal or cardiovascular dysfunction

Pregnancy

Hypersensitivity to aminophylline or other methylxanthines

Chronic therapy with aminophylline or other methylxanthines (to avoid toxic drug levels).

Uncontrolled hypertension and myocardial disease

Patient on following drugs- Macrolides, Calcium channel blockers, Cimetidine, Quinolones, Rifampicin, Carbamazepine, Lithium, Phenytoin.

Chronic smokers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of aminophylline and placebo on BIS scores in patients under isoflurane anaesthesia and to correlate it with clinical recovery charcteristics. <br/ ><br>To compare the effect of aminophylline vs placebo on clinical recovery characteristics in patients undergoing laparoscopic cholecystectomy under isoflurane anaesthesia <br/ ><br>Timepoint: clinical recovery charcteristics and heminodynaminc varibles at removal of laparoscpe and every minute thereafter till extubation.
Secondary Outcome Measures
NameTimeMethod
intraoperative and postoperative hemodymaic stability and postoerative cognitive effect on patientTimepoint: intraoperative and upto 24 hour after surgery
© Copyright 2025. All Rights Reserved by MedPath